<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Approach to systemic therapy in early, hormone receptor-positive, HER2-negative breast cancer</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Approach to systemic therapy in early, hormone receptor-positive, HER2-negative breast cancer</h1>
<div class="graphic"><div class="figure"><div class="ttl">Approach to systemic therapy in early, hormone receptor-positive, HER2-negative breast cancer</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_footnotes">HER2: human epidermal growth factor receptor 2; <em>BRCA</em>: breast cancer susceptibility genes; CPS: clinical and pathologic stage; EG: histologic grade; RS: recurrence score; EP: EndoPredict; PAM50: Predictory Analysis of Microarray 50; MammaPrint: Amsterdam 70-gene profile.<br/>* High-risk criteria for hormone receptor-positive cancers, according to the OlympiA trial:<sup>[1]</sup>
<ul>
<li>If treated with adjuvant chemotherapy, patients were required to have &gt;3 pathologically confirmed positive lymph nodes.</li>
<li>If treated with neoadjuvant chemotherapy, patients were required to not have experienced a pathologic complete response, and to have a CPS+EG score of 3 or higher.<sup>[2]</sup> The CPS+EG scoring system estimates relapse probability on the basis of clinical and pathologic stage (CPS) and estrogen receptor status and histologic grade (EG); scores range from 0 to 6, with higher scores indicating worse prognosis. The CPS+EG calculator is available online at <a href="https://www3.mdanderson.org/app/medcalc/index.cfm?pagename=bcnt" target="_blank">www3.mdanderson.org/app/medcalc/index.cfm?pagename=bcnt</a>.</li>
</ul>

¶ Among the gene expression profiles, the Oncotype DX 21-gene RS is the most well validated. Others include EP, PAM50, Breast Cancer Index, and MammaPrint.</div><div class="graphic_reference">References:

<ol>
<li>Tutt ANJ, Garber JE, Kaufman B, et al. Adjuvant olaparib for patients with BRCA1- or BRCA2-mutated breast cancer. N Engl J Med 2021; 384:2394.</li>
<li>Mittendorf EA, Jeruss JS, Tucker SL, et al. Validation of a novel staging system for disease-specific survival in patients with breast cancer treated with neoadjuvant chemotherapy. J Clin Oncol 2011; 29:1956.</li>
</ol></div><div id="graphicVersion">Graphic 132496 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
